Page 1 of Clinical Trials for Biological MEDI-534, 3 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
A Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to < 24 Month-Old Children and in 2 Month Old Infants
Last Updated: May 18, 2012
Condition(s): Respiratory Syncytial Virus (RSV); Parainfluenza Virus Type 3 (PIV3)
2
Completed
Study to Evaluate the Safety of MEDI-534 Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3) in Healthy Children
Last Updated: September 2, 2008
Condition(s): Healthy
3
Completed
Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age
Last Updated: March 12, 2012
Condition(s): Respiratory Viral Infections; Respiratory Syncytial Virus Infections; Parainfluenza Virus 3, Human

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Biological+MEDI-534

Page 1 of Clinical Trials for Biological MEDI-534, 3 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About